X4 Pharmaceuticals, Inc.
NASDAQ:XFOR
0.7032 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 99.466 | 121.718 | 81.787 | 78.708 | 126.184 | 30.754 | 76.793 | 3.035 | 6.759 |
| Short Term Investments
| 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 114.466 | 121.718 | 81.787 | 78.708 | 126.184 | 30.754 | 76.793 | 3.035 | 6.759 |
| Net Receivables
| 0.562 | 1.152 | 0.747 | 0.917 | 1.998 | 2.859 | 1.608 | 1.345 | 1.541 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0.355 | 1.246 | 0 |
| Other Current Assets
| 7.048 | 5.807 | 5.344 | 3.682 | 1.096 | 1.467 | 2.077 | 0.09 | 0.087 |
| Total Current Assets
| 122.076 | 128.677 | 87.878 | 83.307 | 129.278 | 35.08 | 80.833 | 5.716 | 8.387 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 6.395 | 8.333 | 10.224 | 9.197 | 2.362 | 0.285 | 0.421 | 0.519 | 0.76 |
| Goodwill
| 17.351 | 17.351 | 17.351 | 27.109 | 27.109 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 17.351 | 17.351 | 17.351 | 27.109 | 27.109 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.782 | 1.025 | 1.321 | 1.73 | 1.902 | 0.364 | 0.355 | 0.394 | 0.338 |
| Tax Assets
| 0 | -1.025 | -1.321 | -1.73 | -1.902 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.654 | 1.225 | 1.723 | 3.258 | 1.949 | 0.275 | -0.355 | 0.975 | 0.025 |
| Total Non-Current Assets
| 25.182 | 26.909 | 29.298 | 39.564 | 31.42 | 0.924 | 0.421 | 1.888 | 1.123 |
| Total Assets
| 147.258 | 155.586 | 117.176 | 122.871 | 160.698 | 36.004 | 81.254 | 7.604 | 9.51 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 8.947 | 7.777 | 4.283 | 3.144 | 2.088 | 0.545 | 1.893 | 1.645 | 0.423 |
| Short Term Debt
| 1.099 | 2.513 | 1.87 | 0.786 | 0.898 | 1.687 | 2.314 | 5.162 | 2.49 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0.737 | 2.63 | 0.504 | 0.43 |
| Other Current Liabilities
| 12.816 | 12.034 | 7.87 | 8.018 | 6.461 | 2.429 | 0.844 | 4.749 | 3.334 |
| Total Current Liabilities
| 22.862 | 22.324 | 14.023 | 11.948 | 9.447 | 5.398 | 7.681 | 12.06 | 6.677 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 54.57 | 35.907 | 37.915 | 37.662 | 22.015 | 7.894 | 12.236 | 10.127 | 4.704 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 1.107 | 2.63 | 2.054 | 2.433 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | -0.009 | 39.838 | 29.948 |
| Other Non-Current Liabilities
| 18.727 | 23.304 | 0.826 | 0.462 | 0.016 | 0.005 | 0.009 | 0.087 | 0.07 |
| Total Non-Current Liabilities
| 73.297 | 59.211 | 38.741 | 38.124 | 22.031 | 9.006 | 14.866 | 52.106 | 37.155 |
| Total Liabilities
| 96.159 | 81.535 | 52.764 | 50.072 | 31.478 | 14.404 | 22.547 | 64.166 | 43.832 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 160.698 | 65.409 | 81.254 | 39.838 | 29.948 |
| Common Stock
| 0.167 | 0.122 | 0.028 | 0.016 | 0.016 | 0.015 | 0.015 | 0.001 | 0.001 |
| Retained Earnings
| -477.905 | -376.738 | -282.871 | -194.175 | -132.044 | -135.286 | -92.265 | -58.388 | -35.413 |
| Accumulated Other Comprehensive Income/Loss
| -0.119 | -0.119 | -0.119 | -0.119 | -0.119 | 0.241 | 0.127 | 0.834 | 0.718 |
| Other Total Stockholders Equity
| 528.956 | 450.786 | 347.374 | 267.077 | 100.669 | 91.221 | 69.576 | -38.847 | -29.576 |
| Total Shareholders Equity
| 51.099 | 74.051 | 64.412 | 72.799 | 129.22 | 21.6 | 58.707 | -56.562 | -34.322 |
| Total Equity
| 51.099 | 74.051 | 64.412 | 72.799 | 129.22 | 21.6 | 58.707 | -56.562 | -34.322 |
| Total Liabilities & Shareholders Equity
| 147.258 | 155.586 | 117.176 | 122.871 | 160.698 | 36.004 | 81.254 | 7.604 | 9.51 |